Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (171-180 of 260) with videos related to

Pageof 26
Sort By:
Bipolar Disorders|December 23, 2020
Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithmsNorma Verdolini, Diego Hidalgo-Mazzei, Laura Del Matto, et al.
Schizophrenia Research|September 9, 2008
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment StudyKeith A Hawkins, Richard S E Keefe, Bruce K Christensen, et al.
The Journal of Clinical Psychiatry|January 30, 2020
A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive DyskinesiaStanley N Caroff, Leslie Citrome, Jonathan Meyer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 21, 2021
White Matter Abnormalities in Late Onset First Episode Mania: A Diffusion Tensor Imaging StudyJesus Ramírez-Bermúdez, Oscar Marrufo-Melendez, Cecilia Berlanga-Flores, et al.
Psychoneuroendocrinology|November 21, 2019
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorderAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
Journal of Mood and Anxiety Disorders|August 28, 2025
Clinical decision support for pharmacologic management of treatment-resistant depression with augmented large language modelsRoy H Perlis, Pilar F Verhaak, Joseph Goldberg, et al.
JMIR Mental Health|March 10, 2021
Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness StudyAnastasiya Nestsiarovich, Praveen Kumar, Nicolas Raymond Lauve, et al.
Biological Psychiatry|September 6, 2005
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosisRichard S E Keefe, Larry J Seidman, Bruce K Christensen, et al.
The Journal of Clinical Psychiatry|November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyMauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
Psychopharmacology Bulletin|June 7, 2021
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar DisorderCharles L Bowden, Richard Priesmeyer, Mauricio Tohen, et al.
Pageof 26

Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
Bipolar Disorders|December 23, 2020
Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithmsNorma Verdolini, Diego Hidalgo-Mazzei, Laura Del Matto, et al.
Schizophrenia Research|September 9, 2008
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment StudyKeith A Hawkins, Richard S E Keefe, Bruce K Christensen, et al.
The Journal of Clinical Psychiatry|January 30, 2020
A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive DyskinesiaStanley N Caroff, Leslie Citrome, Jonathan Meyer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 21, 2021
White Matter Abnormalities in Late Onset First Episode Mania: A Diffusion Tensor Imaging StudyJesus Ramírez-Bermúdez, Oscar Marrufo-Melendez, Cecilia Berlanga-Flores, et al.
Psychoneuroendocrinology|November 21, 2019
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorderAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
Journal of Mood and Anxiety Disorders|August 28, 2025
Clinical decision support for pharmacologic management of treatment-resistant depression with augmented large language modelsRoy H Perlis, Pilar F Verhaak, Joseph Goldberg, et al.
JMIR Mental Health|March 10, 2021
Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness StudyAnastasiya Nestsiarovich, Praveen Kumar, Nicolas Raymond Lauve, et al.
Biological Psychiatry|September 6, 2005
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosisRichard S E Keefe, Larry J Seidman, Bruce K Christensen, et al.
The Journal of Clinical Psychiatry|November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyMauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
Psychopharmacology Bulletin|June 7, 2021
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar DisorderCharles L Bowden, Richard Priesmeyer, Mauricio Tohen, et al.
Pageof 26